Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort

Background:Venous thromboembolism (VTE) is a major source of morbidity and mortality in cancer patients. Incident colorectal cancer (CRC) and comorbidity both predict VTE, but potential synergy between these factors has not been explored.Methods:Danish nationwide cohort study of CRC cases diagnosed in 1995–2010 and a matched general population reference cohort of subjects without CRC who matched cases on age, sex, and comorbidities. We calculated the Charlson Comorbidity Index using diagnoses recorded in the Danish National Patient Registry. We calculated standardised incidence rates (SIRs) and interaction contrasts (IC) to measure additive interaction between comorbidity and CRC status with respect to 5-year VTE incidence.Results:Among 56 189 CRC patients, 1372 VTE cases were diagnosed over 145 211 person-years (SIR=9.5 cases per 1000 person-years). Among 271 670 reference subjects, 2867 VTE cases were diagnosed over 1 068  860 person-years (SIR=2.8 cases per 1000 person-years). CRC and comorbidity were positively and independently associated with VTE, but there was no evidence for biological interaction between these factors (e.g., comparing the ‘severe comorbidity’ stratum with the ‘no comorbidity’ stratum, IC=0.8, 95% CI: −3.3, 4.8).Conclusions:There is neither a deficit nor a surplus of VTE cases among patients with both comorbidity and CRC, compared with rates expected from these risk factors in isolation.

[1]  S Greenland,et al.  Concepts of interaction. , 1980, American journal of epidemiology.

[2]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[3]  H. Storm,et al.  The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.

[4]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[5]  L Frank,et al.  When an Entire Country Is a Cohort , 2000, Science.

[6]  M. Samama,et al.  The Thrombophilic State in Cancer Patients , 2001, Acta Haematologica.

[7]  S. Kahn,et al.  Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. , 2002, Archives of internal medicine.

[8]  F. Rosendaal,et al.  Malignancies, prothrombotic mutations, and the risk of venous thrombosis. , 2005, JAMA.

[9]  J. Coebergh,et al.  Which Comorbid Conditions Predict Complications after Surgery for Colorectal Cancer? , 2005, World Journal of Surgery.

[10]  P. Mortensen,et al.  The Danish Civil Registration System. A cohort of eight million persons. , 2006, Danish medical bulletin.

[11]  H. Chew,et al.  Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Chew,et al.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers. , 2006, Archives of internal medicine.

[13]  P. Prandoni,et al.  Cancer and venous thromboembolism. , 1996, Seminars in thrombosis and hemostasis.

[14]  A. Khorana,et al.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients , 2008, Cancer.

[15]  M. Cushman Epidemiology and risk factors for venous thrombosis. , 2007, Seminars in hematology.

[16]  D. Chang,et al.  Postoperative Venous Thromboembolism Rates Vary Significantly After Different Types of Major Abdominal Operations , 2008, Journal of Gastrointestinal Surgery.

[17]  Miriam Lopez Gomez,et al.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients , 2008, Cancer.

[18]  R. White,et al.  Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors , 2009, Cancer investigation.

[19]  A. Khorana,et al.  Assessing risk of venous thromboembolism in the patient with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  C. Marosi,et al.  Prediction of venous thromboembolism in cancer patients. , 2010, Blood.

[21]  Marianne Lundkjær Gjerstorff,et al.  The Danish Cancer Registry , 2011, Scandinavian journal of public health.

[22]  Vasiliki Kyriazi,et al.  Assessing the risk and prognosis of thrombotic complications in cancer patients. , 2013, Archives of pathology & laboratory medicine.

[23]  M. Borre,et al.  Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients , 2014, Clinical epidemiology.

[24]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[25]  R. Rosenfeld Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[26]  E. Horváth-Puhó,et al.  30-Year Mortality After Venous Thromboembolism: A Population-Based Cohort Study , 2014, Circulation.

[27]  I. Pabinger,et al.  Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS). , 2014, Thrombosis research.

[28]  John A. Heit,et al.  The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.